Fig. 1From: The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patientsInstitutional-invasive samples comparing guideline-adherent and -divergent treated patients. Cohort 1996–97 (left) and cohort 2003–04 (right)Back to article page